Cardiac adaptive responses after hypoxia in an experimental model

Angiology

Volumn 61, Issue 2, 2010, Pages 145-156

  Bin Jaliah, Ismaeel ^a   Ammar, Hania I ^b   Mikhailidis, Dimitri P ^c   Dallak, Mohammed A ^a   Al Hashem, Fahaid H ^a   Haidara, Mohamed A ^a   Yassin, Hanaa Z ^b   Bahnasi, Abeer A ^b   Rashed, Laila A ^a   Isenovic, Esma R ^d  

^a KING KHALID UNIVERSITY   (Saudi Arabia)

^b CAIRO UNIVERSITY   (Egypt)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Acuteintermittenthypoxia; hypoxicpreconditioning; Erythropoietin; Vascular endothelial growth factor

Indexed keywords

ERYTHROPOIETIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART RATE; HYPOXIA; IMMUNOHISTOCHEMISTRY; ISOLATION PROCEDURE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REOXYGENATION; REVERSE TRANSCRIPTION; RNA ISOLATION;

EID: 76649129859     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319709352486     Document Type: Article

References (60)

1. Kolar F., Ostadal B. Molecular mechanisms of cardiac protection by adaptation to chronic hypoxia. Physiol Res. 2004 ; 53 (suppl 1). S3 - S13.
2. Murry CE, Jennings RB, Reimer KA Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986 ; 74 (5). 1124-1136.
3. Bolli R. The late phase of preconditioning. Circulation Res. 2000 ; 87 (11). 972-983.
4. Marber MS, Latchman DS, Walker JM, Yellon DM Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation. 1993 ; 88 (3). 1264-1272.
5. Bolli R. The early and late phases of preconditioning against myocardial stunning and the essential role of oxy-radicals in the late phase: an overview. Basic Res Cardiol. 1996 ; 91 (1). 57-63.
6. Rogen GA, Smits P., Riksen NP Ischemic preconditioning: from molecular characterization to clinical application-part I. Neth J Med. 2004 ; 62 (11). 353-363. (Pubitemid 39549518)
7. Solomon SD, Anavekar NS, Greaves S., et al. Heart Investigators. Angina pectoris prior to myocardial infarction protects against subsequent left ventricular remodeling. J Am Coll Cardiol. 2004 ; 43 (9). 1515-1516.
8. Buykates M., Kalycioglu S., Oz E., Soncul H. Effects of ischemic preconditioning in human heart. J Card Surg. 2005 ; 20 (3). 241-245.
9. Powell FL, Garcia N. Physiological effects of intermittent hypoxia. High Alt Med Biol. 2000 ; 1 (2). 125-136.
10. Lasley RD, Anderson GM, Mentzer RM Ischemic and hypoxic preconditioning enhance postischemic recovery of function in the rat heart. Cardiovasc Res. 1993 ; 27 (4). 565-570.
11. Ostadalova I., Ostadal B., Jarkovska D., Kolar F. Ischemic preconditioning in chronically hypoxic neonatal rat heart. Pediatr Res. 2002 ; 52 (4). 561-567.
12. Rafiee P., Shi Y., Kong X., et al. Activation of protein kinases in chronically hypoxic infant human and rabbit hearts: role in cardioprotection. Circulation. 2002 ; 106 (2). 239-245.
13. Stroka DM, Burkhardt T., Desbaillets I., et al. HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J. 2001 ; 15 (13). 2445-2453.
14. Fong GH, Rossant J., Gerstenstein M., Breitman ML Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature. 1995 ; 376 (6535). 66-70.
15. Maruyama K., Mori Y., Murasawa S., et al. Interlukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptors KDA/FLK-1 via activation of protein tyrosine kinases. J Mol Cell Cardiol. 1999 ; 31 (3). 607-617.
16. Takeshita S., Zheng LP, Brogi E., Kearney M., Pu LQ Therapeutic angiogenesis: a single intra arterial bolus of vascular endothelial growth factoraugments revascularization in a rabbit ischemic hind limb model. J Clin Invest. 1994 ; 93 (2). 662-670.
17. Hashimoto E., Teruhiko O., Takashi N., et al. Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am J Physiol. 1994 ; 267 (5 pt 2). H1948 - H1954.
18. Isner JM Myocardial gene therapy. Nature. 2002 ; 415: 234-239.
19. Matsunaga T., Warltier DC, Tessmer J., et al. Expression of VEGF and angiopoietins-1 and -2 during ischemia induced coronary angiogenesis. Am J Physiol Heart Circ Physiol. 2003 ; 285 (1). H352 - H358.
20. Symes JF, Isner JM, Ferrar N., et al. Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury. Ann Thorac Surg. 1997 ; 64 (4). 993-998.
21. Semenza GL, Wang GL A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol. 1992 ; 12 (12). 5447-5454.
22. Wang GL, Semenza GL General Involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. PNAS. 1993 ; 90 (9). 4304-4430.
23. Maxwell PH, Pugh CW, Ratcliffe PJ Inducible operation of the erythropoietin 3' enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism. PNAS. 1993 ; 90 (6). 2423-2427.
24. Jelkman W. Biology of erythropoietin. Clin Investig. 1994 ; 72: S3 - S10.
25. Fisher JW Erythropoietin: physiology and pharmacology update. Exp Biol Med. 2003 ; 228 (1). 1-14.
26. Marti HH Erythropoietin and the hypoxic brain. J Exper Biol. 2004 ; 207 (pt 18). 3233-3242.
27. Tudor RM, Flook BA, Voelkel NF Increased gene expression for VEGF and the VEGF receptors KDR/ FLKand flt in lungs exposed to acute and chronic hypoxia. Modulation of gene expression by Nitric oxide. J Clin Invest. 1995 ; 95 (4). 1798-1807.
28. Hurtado A. Some clinical aspects of life at high altitudes. Ann Intern Med. 1960 ; 53: 247-258.
29. Poupa O., Krofta K., Prochazka J., Turek Z. Acclimatization to simulated high altitude and acute cardiac necrosis. Fed Proc. 1966 ; 25 (4). 1243-1246.
30. McGrath JJ, Prochazk J., Pelouch V., Ostadal B. Physiological response of rats to intermittent high altitude stress: effect of age. J Appl Physiol. 1973 ; 34 (3). 289-293.
31. Tajima M., Katayose D., Bessho M., Isoyama S. Acute ischemic preconditioning and chronic hypoxia independently increase myocardial tolerance to ischemia. Cardiovasc Res. 1994 ; 28 (3). 312-319.
32. Dong JW, Zhu HF, Zhu WZ, et al. Intermittent hypoxia attenuates ischemia /reperfusion induced apoptosis in cardiac myocytes via regulating Bcl-2/Bax expression. Cell Res. 2003 ; 13 (5). 385-391.
33. Tin'kov AN, Aksenov VA Effects of intermittent hypobaric hypoxia on blood lipid concentrations in male coronary heart disease patients. High Alt Med Biol. 2002 ; 3 (3). 277-282.
34. Engelman DT, Watanabe M., Engelman RM et al. Hypoxic preconditioning preserves antioxidant reserve in the working rat heart. 1995 ;29(1): 133-140.
35. Ray PS, Estrada-Hernandez T., Sasaki H., Zhu L., Maulik N. Early effects of hypoxia/reoxygenation on VEGF, ang-1, ang-2 and their receptors in the rat myocardium: implications for myocardial angiogenesis. Mol Cell Biochem. 2000 ; 213 (1-2). 145-153.
36. Sasaki H., Fukuda S., Otani H., et al. Hypoxic preconditiong triggers myocardial angiogenesis: a Novel approach to enhance contractile functional reserve in rats with myocardial infarction. J Mol Cell Cardiol. 2002 ; 34 (3). 335-348.
37. Zhu HF, Dong JW, Zhu WZ, Ding HL, Zhou ZN ATPdependent potassium channels involved in the cardiac protection induced by intermittent hypoxia against ischemia/reperfusion injury. Life Sci. 2003 ; 73 (10). 1275-1287.
38. Cai Z., Manalo D., Wei G., et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion Injury. Circulation. 2003 ; 108 (1). 79-85.
39. Sasaki H., Ray PS, Zhu L., Galang N., Maulik N. Oxidative stress due to hypoxia /reoxgenation induces angiogenic factor VEGF in adult rat myocardium: possible role of NF Kappa B. Toxicolcogy. 2000 ; 155 (1-3). 27-35.
40. Marfella R., Esposito K., Nappo F., et al. Expression of angiogenic factors during acute coronary syndromes in human type 2 diabetes. Diabetes. 2004 ; 53 (9). 2383-2391.
41. Fukuda S., Zhu Li, Engelman RM, Das DK, Maulik N. Ischemic preconditioning (PC) triggers myocardial angiogenesis by upregulating vascular endothelial growth factor (VEGF). Surgical Forum. 2001 ; LII: 65-67.
42. Ray PS, Estrada-Hernandez T., Sasaki H., Zhu L., Maulik N. Early effects of hypoxia/reoxygenation on VEGF, ang-1, ang-2 and their receptors in the rat myocardium: implications for myocardial angiogenesis. Mol Cell Biochem. 2000 ; 213 (1-2). 145-153.
43. Jelkmann W. Erythropoietin: structure, control of production, and function. Physiological Rev. 1992 ; 72 (2). 449-489.
44. Tomanek RJ, Lund DD, Yue X. Hypoxic induction of myocardial vascularization during development. Adv Exp Med Biol. 2003 ; 543: 139-149.
45. Wu J., Chen I., Wang Y., et al. Molecular imaging of the kinetics of vascular endothelial growth factor expression in ischemic myocardium. Circulation. 2004 ; 110 (6). 685-691.
46. Yokoyama S., Fukuda N., Li Y., et al. A strategy of retrograde injection of bone marrow mononuclear cells into the myocardium for the treatment of ischemic heart disease. J Mol Cell Cardiol. 2006 ; 40 (1). 24-34.
47. Yokoyama S., Fukuda N., Li Y., et al. A strategy of retrograde injection of bone marrow mononuclear cells into the myocardium for the treatment of ischemic heart disease. J Mol Cell Cardiol 2006 ; 40: 24-34.
48. Xi L., Tekin D., Gursoy E., Salloum F., Levasseur JE, Kukreja RC Evidence that NOS2 acts as a trigger and mediator of late preconditioning induced by acute systemic hypoxia. Am J Physiol Heart Circ Physiol. 2002 ; 283 (1). H5-12.
49. Beguin PC, Joyeux-Faure M., Godin-Ribuot D., Levy P., Ribuot C. Acute intermittent hypoxia improves rat myocardium tolerance to ischemia. J Appl Physiol. 2005 ; 99 (3). 1064-1069.
50. Ku DD, Zaleski JK, Liu S., Brock TA Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol. 1993 ; 265 (2 pt 2). H586 - H592.
51. Fukuda S., Kaga S., Sasaki H., et al. Angiogenic signal triggered by ischemic stress induces myocardial repair in rat during chronic infarction. J Molec Cell Cardiol. 2004 ; 36 (4). 574-559.
52. Masuda S., Nagao M., Sasaki R. Erythropoietic, neurotrophic, and angiogenic functions of erythropoietin and regulation of erythropoietin production. Int J Hematol. 1999 ; 70 (1). 1-6.
53. Wright GL, Hanlon P., Amin K., Steenburg et al. Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia reperfusion injury. FASEB J. 2004 ; 18 (9). 1031-1033.
54. Cai Z., Semenza GL Phosphatidylinositol-3kinase sinaling is required for erythropoietin -mediated acute protection against myocardial ischemia/reperfusion injury. Circulation. 2004 ; 109: 2050-2053.
55. Lipsic E., Van der Meer P., Henning RH, et al. Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion. J Cardiovasc Pharmacol. 2004 ; 44 (4). 473-479.
56. Chanil M., Melissa K., Dongchoon A. et al. Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats. PNAS. 2003 ; 100 (20). 11612-11617.
57. Parsa CJ, Matsumoto A., Kim J., et al. A novel protective effect of erythropoietin in the infracted heart. J Clin Invest. 2003 ; 112 (7). 99-1007.
58. John EB Erythropoietin mimics ischemic preconditioning. Vasc Pharmacol. 2005 ; 42 (5-6). 233-241.
59. Van der Meer P., Lipsic E., Henning RH, et al. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction. J Am Coll Cardiol. 2005 ; 46 (1). 125-133.
60. Scalia R., Booth G., Lefer D. Vascular endothelial growth factor attenuates leukocyte-endothelium interaction during acute endothelial dysfunction: essential role of endothelium-derived nitric oxide. FASEB J. 1999 ; 13 (1). 1039-1046.